The mission of the Tufts Health Care Institute Program on Opioid Risk Management is to address challenges in the development and utilization of opioid analgesics, by engaging a multidisciplinary group of stakeholders focused on optimizing the benefits of opioid for pain management, and minimizing their risks, including abuse and diversion.

June 9-10, 2011

Agenda Executive Summary

The drive to develop medications for prescription opioid abuse: A historical overview of the development of methadone, buprenorphine, and naltrexone
Frank Vocci, PhD Presentation >>

The epidemiology of co-morbid pain and substance abuse
Nathaniel Katz, MD, MS Presentation >>

Health economics of prescription opioid abuse and its treatment
Howard Birnbaum, PhD,
Alan White, PhD Presentation >>

Efficacy of methadone for opioid replacement therapy
Mark Parrino, MPA Presentation >>

Efficacy of naltrexone for opioid addiction
Sandra Comer, PhD Presentation >>

Buprenorphine and methadone in the treatment of pain
Doug Gourlay Presentation >>

Efficacy of buprenorphine for prescription opioid addiction
Roger Weiss, MD Presentation >>

Acute and chronic pain management in patients receiving pharmacotherapy for addiction
Daniel Alford, MD Presentation >>

Pharmacotherapy for opioid addiction: Drugs in development
Walter Ling, MD Presentation >>

Epidemic: Responding to America’s Prescription Drug Crisis
Timothy Condon, PhD Presentation >>

Regulatory considerations for an opioid analgesic indicated for use in patients with addiction
Deborah Leiderman, MD Presentation >>